Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
RareCyte
company
About
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series G
- Last Funding Money Raised
- $24M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$24M
RareCyte has raised a total of
$24M
in funding over 2 rounds. Their latest funding was raised on
Sep 9, 2021 from a Series G round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 9, 2021 | Series G | $24M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
RareCyte is funded by 1 investors.
Agilent Technologies
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Agilent Technologies
|
— | Series G |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
